Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

ADx NeuroSciences NV Company Overview 4

ADx NeuroSciences NV Company Snapshot 4

ADx NeuroSciences NV Pipeline Products and Ongoing Clinical Trials Overview 4

ADx NeuroSciences NV – Pipeline Analysis Overview 6

ADx NeuroSciences NV - Key Facts 6

ADx NeuroSciences NV - Major Products and Services 7

ADx NeuroSciences NV Pipeline Products by Development Stage 8

ADx NeuroSciences NV Pipeline Products Overview 10

ADDL'S Biomarker Test 10

ADDL'S Biomarker Test Product Overview 10

Alpha-Synuclein Biomarker Test 11

Alpha-Synuclein Biomarker Test Product Overview 11

APO E4 Biomarker Test 12

APO E4 Biomarker Test Product Overview 12

BACE 1 Biomarker Test 13

BACE 1 Biomarker Test Product Overview 13

Blood Based Amyloid Beta Biomarker Test 14

Blood Based Amyloid Beta Biomarker Test Product Overview 14

Cerebrospinal Fluid Based Amyloid Beta Biomarker Test 15

Cerebrospinal Fluid Based Amyloid Beta Biomarker Test Product Overview 15

GLOB. P3N Aß Biomarker Test 16

GLOB. P3N Aß Biomarker Test Product Overview 16

Neurofilament Biomarker Test 17

Neurofilament Biomarker Test Product Overview 17

Neurogranin Biomarker Test 18

Neurogranin Biomarker Test Product Overview 18

O-TAU Biomarker Test 19

O-TAU Biomarker Test Product Overview 19

P-tau Biomarker Test 20

P-tau Biomarker Test Product Overview 20

SNAP 25 Biomarker Test 21

SNAP 25 Biomarker Test Product Overview 21

Synuclein Oligo Biomarker Test 22

Synuclein Oligo Biomarker Test Product Overview 22

Total Tau Biomarker Test - Traumatic Brain Injury 23

Total Tau Biomarker Test - Traumatic Brain Injury Product Overview 23

ADx NeuroSciences NV - Key Competitors 24

ADx NeuroSciences NV - Key Employees 25

ADx NeuroSciences NV - Locations And Subsidiaries 26

Head Office 26

Appendix 27

Methodology 27

About GlobalData 30

Contact Us 30

Disclaimer 30

Summary

ADx NeuroSciences NV (ADx NeuroSciences) is a medical device company that develops proprietary biomarkers for various neurodegenerative diseases. The company offers biomarkers for Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. It also develops and commercializes analytical and clinical validated biomarker kits. ADx NeuroSciences’ biomarkers are used to develop high-quality detection assays and diagnose disease progression. The company partners with academic research center, pharmaceutical industry, in-vitro diagnostic and technology platform companies. ADx NeuroSciences is headquartered in Ghent, Belgium.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ADx NeuroSciences NV
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company